AS

Anita Sunil Patil

Active Director Director DIN 10233269
DIN 10233269 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Anita Sunil Patil

Data last updated:

Anita Sunil Patil is a Director at Syncore Pharmaceuticals Private Limited (since 2023). The company operates in Paper.

DIN 10233269
Primary Designation Director
Industry Paper
First Appointment 10 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20232023Active

Board colleagues of Anita Sunil Patil

NameDINCompanyDesignation
Sanjay Rajgonda Patil10233272Syncore Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Syncore Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anita Sunil Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Sunil Patil

Anita Sunil Patil currently holds 1 directorship: Syncore Pharmaceuticals Private Limited (Director, since 10 Jul 2023).

Anita Sunil Patil was first appointed on 10 Jul 2023 as Director at Syncore Pharmaceuticals Private Limited.

The current boards of Anita Sunil Patil's companies include Sanjay Rajgonda Patil (Syncore Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available